Please assess the completion status of the following clinical trial:

Trial Title: Study of Aripiprazole in Patients With Bipolar I Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of bipolar I disorder, manic or mixed episode~Exclusion Criteria:~* First manic or mixed episode~* Allergic, intolerant, or unresponsive to lithium and valproate or to aripiprazole~* Participation in a previous clinical trial within the past month or ever participated in a trial with aripiprazole

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).